Scarica l'app Stockscreener
21.02
1.50%
0.31
Precedente Chiudi:
$20.71
Aprire:
$20.87
Volume 24 ore:
874.29K
Relative Volume:
0.92
Capitalizzazione di mercato:
$2.58B
Reddito:
$1.80B
Utile/perdita netta:
$15.62M
Rapporto P/E:
175.17
EPS:
0.12
Flusso di cassa netto:
$118.36M
1 W Prestazione:
+6.27%
1M Prestazione:
+2.69%
6M Prestazione:
-15.48%
1 anno Prestazione:
+4.84%
Intervallo 1D:
$20.84
$21.30
Intervallo di 1 settimana:
$19.08
$21.30
Portata 52W:
$16.47
$26.09
Privia Health Group Inc Stock (PRVA) Company Profile
Nome
Privia Health Group Inc
Settore
Industria
Telefono
571-366-8850
Indirizzo
950 N. GLEBE RD., SUITE 700, ARLINGTON
Confronta PRVA con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
PRVA
Privia Health Group Inc
|
21.02 | 2.54B | 1.80B | 15.62M | 118.36M | 0.12 |
|
VEEV
Veeva Systems Inc
|
279.18 | 45.01B | 2.86B | 780.66M | 1.19B | 4.72 |
|
TEM
Tempus Ai Inc
|
69.63 | 11.53B | 803.32M | -709.10M | -212.68M | -7.8003 |
|
DOCS
Doximity Inc
|
64.02 | 11.58B | 550.17M | 201.35M | 232.07M | 1.00 |
|
HQY
Healthequity Inc
|
89.27 | 8.04B | 1.15B | 96.70M | -161.99M | 1.09 |
|
WAY
Waystar Holding Corp
|
35.35 | 6.03B | 906.14M | -52.62M | 89.62M | -0.3621 |
Privia Health Group Inc Stock (PRVA) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-01-10 | Iniziato | Needham | Buy |
| 2024-12-16 | Iniziato | Macquarie | Outperform |
| 2024-10-11 | Iniziato | KeyBanc Capital Markets | Overweight |
| 2024-05-30 | Iniziato | Robert W. Baird | Outperform |
| 2024-04-22 | Iniziato | Citigroup | Buy |
| 2024-03-06 | Iniziato | Barclays | Equal Weight |
| 2024-02-26 | Ripresa | Jefferies | Buy |
| 2024-02-22 | Downgrade | BofA Securities | Buy → Neutral |
| 2023-12-06 | Iniziato | JMP Securities | Mkt Outperform |
| 2023-06-13 | Iniziato | Evercore ISI | Outperform |
| 2023-04-12 | Iniziato | Stephens | Overweight |
| 2023-03-10 | Iniziato | RBC Capital Mkts | Outperform |
| 2023-02-03 | Iniziato | Goldman | Buy |
| 2022-12-09 | Iniziato | Stifel | Buy |
| 2022-12-08 | Iniziato | UBS | Buy |
| 2022-09-07 | Ripresa | Truist | Buy |
| 2022-05-03 | Iniziato | BofA Securities | Buy |
| 2022-04-28 | Iniziato | BTIG Research | Buy |
| 2022-04-01 | Ripresa | Credit Suisse | Outperform |
| 2022-03-30 | Iniziato | Guggenheim | Buy |
| 2022-02-22 | Aggiornamento | Cowen | Market Perform → Outperform |
| 2022-01-03 | Iniziato | Jefferies | Buy |
| 2021-09-27 | Iniziato | SVB Leerink | Outperform |
| 2021-09-10 | Iniziato | Cowen | Market Perform |
| 2021-05-24 | Iniziato | Canaccord Genuity | Buy |
| 2021-05-24 | Iniziato | Credit Suisse | Outperform |
| 2021-05-24 | Iniziato | JP Morgan | Overweight |
| 2021-05-24 | Iniziato | Piper Sandler | Overweight |
| 2021-05-24 | Iniziato | Truist | Buy |
| 2021-05-24 | Iniziato | William Blair | Outperform |
Mostra tutto
Privia Health Group Inc Borsa (PRVA) Ultime notizie
Privia Health’s SWOT analysis: capital-efficient model drives stock growth - Investing.com
Truist Financial Maintains Privia Health(PRVA.US) With Buy Rating, Announces Target Price $30 - 富途牛牛
Barclays Maintains Hold Rating for Privia Health Group with $21 Target - AInvest
3 Stocks Estimated To Be Trading At Discounts Up To 48.8% - simplywall.st
Privia Health Group (PRVA) Gets a Buy from Piper Sandler - The Globe and Mail
PRVA Q2 Deep Dive: Platform Growth, Provider Expansion, and Margin Stability Drive Outperformance - Yahoo Finance
Key metrics from Privia Health Group Inc.’s quarterly dataTechnical Entry Plan with Risk Minimization - Newser
Privia Health Group Inc. stock prediction for this weekFree Triple Digit Growth Focused Trade Plan - Newser
Piper Sandler Maintains Privia Health(PRVA.US) With Buy Rating, Cuts Target Price to $35 - 富途牛牛
Piper Sandler lowers Privia Health stock price target to $35 from $36 - Investing.com Nigeria
Volume Surge May Signal Institutional Interest in Privia Health Group Inc.Weekly Stock Opportunity Radar Scanner Activated - beatles.ru
Privia Health Group shares rise 5.33% intraday after Q2 2025 earnings call. - AInvest
Privia Health Group Maintains Buy Rating and $32 Price Target - AInvest
Privia Health Group Stocks Surge Amid Strong Q2 Results - TipRanks
Privia Health Group: Strong Performance and Promising Outlook Justify Buy Rating - TipRanks
Privia Health: Q2 Earnings Snapshot - Greenwich Time
Privia Health raises 2025 outlook above prior range as implemented providers climb 13.8% and value-based lives grow 15.2% - MSN
Privia Health Reports Strong Q2 2025 Financial Results - TipRanks
Privia Health's Q2 2025 Earnings: Navigating Earnings Disappointments While Fueling Sustainable Growth - AInvest
Transcript : Privia Health Group, Inc., Q2 2025 Earnings Call, Aug 07, 2025 - MarketScreener
Privia Health Group: Strong Buy Rating Backed by Robust Financial Performance and Strategic Expansion - TipRanks
Privia Health shares rise 2.10% after-hours after reporting Q2 revenue of $521.2M, beating estimates. - AInvest
Privia Health (NASDAQ:PRVA) Reports Upbeat Q2 - Yahoo Finance
Privia Health Group shares fall 2.25% intraday after missing Q2 earnings expectations. - AInvest
Privia Health Group Inc reports results for the quarter ended June 30Earnings Summary - TradingView
Earnings call transcript: Privia Health Q2 2025 misses EPS expectations By Investing.com - Investing.com South Africa
Earnings call transcript: Privia Health Q2 2025 misses EPS expectations - Investing.com
Compared to Estimates, Privia Health (PRVA) Q2 Earnings: A Look at Key Metrics - Yahoo Finance
Privia Health Group, Inc. SEC 10-Q Report - TradingView
Privia Health Group earnings missed by $0.03, revenue topped estimates - Investing.com Canada
Privia Health (PRVA) Misses Q2 Earnings Estimates - Yahoo Finance
Privia Health Group Stocks Surge on Strong Outlook - TipRanks
Privia Health Q2 2025 slides: Strong growth and raised guidance, but shares plunge - Investing.com
Privia Health Q2 revenue misses estimates - MarketScreener
Privia Health Reports Second Quarter 2025 Financial Results - The Manila Times
Privia Health Reports Second Quarter 2025 Financial Results - GlobeNewswire Inc.
Statistical indicators supporting Privia Health Group Inc.’s strengthFree Short Term High Yield Stock Tips - Newser
Strategies to average down on Privia Health Group Inc.Daily Exit and Entry Price Prediction - Newser
How to use Fibonacci retracement on Privia Health Group Inc.Free Access to Real-Time Trade Insights - Newser
Will Privia Health Group Inc. bounce back from current supportFree High Growth Low Risk Stock Selection - Newser
Custom watchlist performance reports with Privia Health Group Inc.Growth Projection Summary for Long-Term Investors - Newser
Why Privia Health Group Inc. is moving todayTrend Reversal Probability Forecast Update - Newser
Is Privia Health (PRVA) a Buy Before Earnings Amid Strong Revenue Growth and Rising Analyst Confidence? - AInvest
How to track smart money flows in Privia Health Group Inc.Free Growth Based Investment Plan Guidance - Newser
Privia Health (PRVA) Reports Q2: Everything You Need To Know Ahead Of Earnings - Yahoo Finance
How Privia Health Group Inc. stock performs during market volatilityPredictive Analytics for Equity Growth Potential - Newser
How to recover losses in Privia Health Group Inc. stockSmart Stock Forecast Using AI Algorithms - Newser
Published on: 2025-08-05 20:19:02 - Newser
Is Privia Health Group Inc. stock entering bullish territoryInvestment Roadmap for High Potential Stocks - Newser
Why Privia Health Group Inc. stock attracts strong analyst attentionFree ROI Driven Equity Selection With Safety - Newser
Visualizing Privia Health Group Inc. stock with heatmapsAlpha Stock Picks with Chart Confirmation - Newser
Privia Health Group Inc Azioni (PRVA) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
11.17%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):